More than 1 in 10 have had genetic tests ordered by a doctor or ordered them directly, a new survey finds. Others say they’re interested, but many have concerns.
As Research & Policy Media Relations Manager at the U-M Institute for Healthcare Policy and Innovation (IHPI), Kara Gavin draws on 25 years of experience in communicating about science, medicine and health policy. Her responsibilities include creating compelling stories about discoveries made by the U-M Medical School's biomedical and mental health researchers, the findings and opinions of the 490 healthcare wonks at the U-M IHPI, and the innovative education available at U-M for future doctors and medical scientists.
Two tiny groups of brain cells, right next to each other, play a key role in driving feeding — and stopping. The brain’s own opioid system also gets involved.
Health care coverage for low-income patients produces fiscal benefits that include lower unpaid debts, fewer bankruptcies and higher credit scores.
Federally recommended “expedited partner therapy” can get antibiotics to both partners quickly. But several barriers can stand in the way.
Benzodiazepines pose special risks to older adults. New research finds many of those who start taking them aren’t stopping.
Universities that sell access to their biobanks to private companies should tell patients and be transparent about how profits are used, a new survey shows.